Imexpharm Market Cap

Imexpharm has a market cap or net worth of 8.30 trillion as of March 6, 2026. Its market cap has increased by 10.45% in one year.

Market Cap

8.30T

Enterprise Value

8.11T

Revenue

2.44T

Ranking

n/a

PE Ratio

27.27

Stock Price

53,900.00

Market Cap Chart

Since April 2, 2007, Imexpharm's market cap has increased from 1.11T to 8.30T, an increase of 648.65%. That is a compound annual growth rate of 11.21%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	8,301.08B	2.67%
Dec 31, 2025	8,085.47B	11.70%
Dec 31, 2024	7,238.42B	82.69%
Dec 29, 2023	3,962.17B	-1.28%
Dec 30, 2022	4,013.63B	-22.62%
Dec 31, 2021	5,187.05B	38.19%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Ha Tay Pharmaceutical JSC	6,267.72B
DHG Pharmaceutical JSC	13.49T
Binh Dinh Pharmaceutical and Medical Equipment JSC	5,045.73B
Cuu Long Pharmaceutical JSC	3,973.43B
Traphaco JSC	2,938.84B
Domesco Medical Import - Export Joint-Stock	2,111.43B
OPC Pharmaceutical JSC	1,441.15B
Central Pharmaceutical Joint Stock Company No3	1,352.35B

Market Cap Rankings